Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs35244862 | chr7:66312374 | C/T | 0.000223 | 177 | 24.85 | 29.57 | 33.17 | KM Plot |
PCPG | rs35249621 | chr2:242528430 | C/A | 4.87E-11 | 177 | 25.87 | 24.7 | 10.3 | KM Plot |
PCPG | rs35255694 | chr15:30956187 | C/CT | 0 | 173 | 27.2 | 23.43 | 3.17 | KM Plot |
PCPG | rs35256197 | chr2:24295030 | A/AT | 0.00011 | 178 | 25.4 | 26.57 | 17.43 | KM Plot |
PCPG | rs35271029 | chr8:74303163 | G/A | 0.00018 | 173 | 25.17 | 25.78 | 43.47 | KM Plot |
PCPG | rs35285305 | chr16:89949205 | G/A | 4.7E-5 | 173 | 25.87 | 21.5 | 36.37 | KM Plot |
PCPG | rs35298309 | chr15:43077001 | T/C | 1.9E-13 | 176 | 25.7 | 24.7 | 25.17 | KM Plot |
PCPG | rs35301488 | chr2:242557179 | A/C | 4.04E-5 | 178 | 25.87 | 26.47 | 20.2 | KM Plot |
PCPG | rs35301668 | chr2:209978567 | AT/A | 5.41E-8 | 176 | 20.03 | 23.53 | 27.27 | KM Plot |
PCPG | rs35303380 | chr3:150863963 | G/C | 5.18E-11 | 172 | 25 | 33.13 | 10.3 | KM Plot |
PCPG | rs35305419 | chr2:24280251 | T/G | 0.000122 | 176 | 25.28 | 27.52 | 17.43 | KM Plot |
PCPG | rs35310651 | chr17:50334040 | C/A | 0.00028 | 170 | 26.12 | 28.38 | 16.33 | KM Plot |
PCPG | rs35311452 | chr17:50295022 | G/A | 3.25E-5 | 178 | 25.53 | 27.95 | 14.43 | KM Plot |
PCPG | rs35317012 | chr22:31647783 | G/GCT | 1.11E-5 | 176 | 25.87 | 13.52 | 1.3 | KM Plot |
PCPG | rs35336033 | chr3:136656794 | AG/A | 0.000323 | 175 | 20.2 | 27.75 | 23.03 | KM Plot |